Press release
Rising Hemophilia Prevalence Driving Growth In The Market: A Key Factor Shaping the Future of the Jivi Market in 2025
Jivi
Increasing instances of hemophilia are predicted to fuel the expansion of the jivi market. Genetic alterations to the X-linked genes responsible for clotting factor production are associated with hemophilia. These alterations result in a deficiency or dysfunction in clotting factor VIII (hemophilia A) or IX (hemophilia B), disrupting the blood's capacity to clot efficiently. Improved diagnostics, heightened awareness, and increased reporting globally contribute to the escalated rates of hemophilia. Jivi benefits patients with hemophilia by supplementing the missing Factor VIII with a lasting recombinant therapy, facilitating blood clotting to manage or avert bleeding episodes. Furthermore, its prolonged half-life minimizes the dosing frequency, improving patient convenience and compliance. For example, the United Kingdom Hemophilia Centre Doctor's Organization, a medical group based in the UK, reported in November 2022 that the new Hemophilia A registrations in the UK increased from 16 in 2021 to 19 in 2022. Consequently, the escalating incidence of hemophilia is boosting the jivi market's growth.
Get Your Jivi Market Report Here:
https://www.thebusinessresearchcompany.com/report/jivi-global-market-report
What is the projected compound annual growth rate (CAGR) of the jivi market from 2025 to 2034, and what factors influence it?
In recent periods, the jivi market has seen an XX (HCAGR). Progressing from $XX million in 2024 to $XX million in 2025, it's predicted to expand at a Compound Annual Growth Rate (CAGR) of XX%. This growth trajectory during the historic period can be credited to various factors including a surge in hemophilia cases, significant investment in research and development, prioritization of prophylactic treatments, worldwide investment in healthcare, and a higher rate of diagnosis.
Anticipations show that the jivi market is on track to experience a XX (FCAGR) within the upcoming years, expanding to $XX million by 2029 with an annual compound growth rate (CAGR) of XX%. This projected growth during the estimated period can be linked to an increase in worldwide healthcare spending, a growing male demographic, positive governmental programs, a heightened focus on individualized medicine, and improvements in awareness and early detection. Key future trends include the advancements in technology, the creation of cutting-edge treatments for hemophilia, the rising acceptance of gene therapy, the innovation of new hemophilia therapies, and a swaying interest towards therapies with extended half-life.
Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20117&type=smp
What are the major segments of the jivi market and their role in driving growth?
The jivi market covered in this report is segmented -
1) By Formulation: Lyophilized Powder For Reconstitution, Ready-to-use Formulations
2) By Route of Administration: Intravenous, Subcutaneous
3) By Indication: Treatment Of Hemophilia A, Prophylaxis, On-demand Treatment For Bleeding Episodes
4) By Distribution Channel: Direct Sales, Wholesalers And Distributors, Retail Pharmacies
5) By End Use: Hospitals, Hemophilia Treatment Centres, Specialty Clinics, Home Healthcare Settings
Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20117
Which regions are key players in the growth of the jivi market?
North America was the largest region in the jivi market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the jivi market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Who are the key firms paving the way for growth in the jivi market?
Major companies operating in the jivi market include Bayer AG
Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/customise?id=20117&type=smp
What Is Covered In The Jivi Global Market Report?
•Market Size Forecast: Examine the jivi market size across key regions, countries, product categories, and applications.
•Segmentation Insights: Identify and classify subsegments within the jivi market for a structured understanding.
•Key Players Overview: Analyze major players in the jivi market, including their market value, share, and competitive positioning.
•Growth Trends Exploration: Assess individual growth patterns and future opportunities in the jivi market.
•Segment Contributions: Evaluate how different segments drive overall growth in the jivi market.
•Growth Factors: Highlight key drivers and opportunities influencing the expansion of the jivi market.
•Industry Challenges: Identify potential risks and obstacles affecting the jivi market.
•Competitive Landscape: Review strategic developments in the jivi market, including expansions, agreements, and new product launches.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Rising Hemophilia Prevalence Driving Growth In The Market: A Key Factor Shaping the Future of the Jivi Market in 2025 here
News-ID: 3937753 • Views: …
More Releases from The Business Research Company
Segment Evaluation and Major Growth Areas in the Personalized Testing and Supple …
The personalized testing and supplements sector is gaining remarkable traction, driven by advancements in technology and a rising consumer focus on tailored health solutions. As more individuals seek customized wellness options, this market is set to experience substantial expansion in the coming years. Here's an in-depth look at its current valuation, key players, significant trends, and the main market segments shaping its future.
Market Valuation and Expansion Forecast for Personalized Testing…
Top Players and Market Competition in the Skin Microbiome Industry
The skin microbiome market is emerging as a significant area of interest due to growing awareness about the critical role of skin health and innovative skincare technologies. As research advances and consumer preferences shift towards more natural and science-backed products, this market is set to undergo substantial growth. Let's explore the current market size, key players, driving factors, and upcoming trends shaping the skin microbiome industry.
Projected Expansion in the Skin…
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market …
The upadacitinib market is poised for significant expansion over the coming years, driven by advances in treatment options and increasing awareness of autoimmune diseases. This report delves into the market's current size, key drivers, major players, and the emerging trends shaping its future trajectory.
Steady Growth Expected in Upadacitinib Market Size Through 2029
The market for upadacitinib is projected to reach $2.54 billion by 2029, growing at a robust compound annual…
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Marke …
The Alzheimer's disease diagnostic sector is rapidly evolving as advancements in technology and healthcare infrastructure open new possibilities for early detection and personalized treatment. With rising awareness and innovative approaches, this market is poised for significant growth in the coming years. Let's explore the current market size, key drivers, leading companies, and emerging trends that are shaping this critical healthcare field.
Projected Market Size and Growth Trends in Alzheimer's Disease Diagnostics…
More Releases for Jivi
Jivi Industry Report 2025-2034: Market Dynamics, Drivers, And Forecasts
The Jivi Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Projected Growth of the Jivi Market?
The jivi market has seen a surge in its size by XX (HCAGR) in the past few years. The market growth is forecasted to rise from $XX…
Coagulation factor deficiency Market: Epidemiology, Therapies, Companies, DelveI …
Coagulation factor deficiency therapies, such as ESPEROCT (N8-GP; Turoctocog alfa pegol), JIVI (formerly BAY94-9027), Concizumab (NN7415), Fidanacogene elaparvovec, RG6357 (SPK-8011), and others, are expected to boost the Coagulation factor deficiency Market in the upcoming years.
DelveInsight has launched a new report on "Coagulation factor deficiency - Market Insights, Epidemiology, and Market Forecast-2034" that delivers an in-depth understanding of the Coagulation factor deficiency, historical and forecasted epidemiology as well as the Coagulation…
Rising Hemophilia Prevalence Driving Growth In The Market: A Key Factor Shaping …
What Are the Projections for the Size and Growth Rate of the Jivi Market?
In recent years, the market size for jivi has grown at an $XX. The market, which was valued at $XX million in 2024, is anticipated to reach $XX million in 2025, corresponding to a compound annual growth rate (CAGR) of $XX%. This expansion during the historic period is due to various factors, including an increased occurrence of…
Hemophilia A Clinical Trials Assessment 2023: FDA Approvals, Treatment drugs, Th …
(New York, USA) DelveInsight's 'Hemophilia A Pipeline Insight 2023' report provides comprehensive global coverage of available, marketed, and pipeline Hemophilia A therapies in various stages of clinical development, major pharmaceutical companies are working to advance the pipeline space and future growth potential of the Hemophilia A pipeline domain.
To know more in detail about Hemophilia A pipeline report, click here: Hemophilia A Pipeline Insight
https://www.delveinsight.com/report-store/hemophilia-a-pipeline-insight-2020?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
For Hemophilia A emerging drugs, the Hemophilia A…
Hemophilia A Market is expected to show positive growth, during the forecast per …
Hemophilia A Market Insights report from DelveInsight provides a thorough understanding of the Hemophilia A Market size by treatment, epidemiology, emerging therapies, market share of the various therapies, and the current and forecasted Hemophilia A Market size from 2019 to 2032 divided into the 7MM (the USA, EU5 (Germany, France, Italy, Spain, and the UK), and Japan) regions.
Key highlights of the Hemophilia A Market Research Report
• According to DelveInsight, the Hemophilia…
Hemophilia A Treatment Market Set to Record Exponential Growth by 2026
Hemophilia A occurs due to a factor VIII deficiency. It is an X-linked chromosomal disease also known as classic hemophilia. Patients inherit the condition as an X-linked trait, and as a result, males are primarily affected by the condition, while females are the carriers of the trait. The condition generally involves genetic inheritance, wherein the trait is passed onto the children by parents. About 33% of the cases involve spontaneous…
